Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

McMaster University

$56,000.00

Role of peptidoglycan-active enzymes in the assembly of bacterial motility, secretion and efflux systems

EF 2011-12

Résumé
Peptidoglycan (PG) is a major structural component of bacterial cell walls but is absent in higher organisms. It is a strong, chain link fence-like material with a pore size of ~100 kDa. It completely surrounds bacteria, providing protection against high internal pressures and contributing to the formation of distinct bacterial cell shapes. Although PG is essential for bacterial viability and was identified decades ago as the target of the earliest antibiotics, the molecular details of its synthesis are only partly understood. In part, this lack of understanding has arisen because most bacteria have multiple, non-essential PG active enzymes with seemingly redundant activities, making it challenging to assign specific functions to individual proteins. Drugs such as penicillin that inhibit PG synthesis often target multiple enzymes simultaneously, making it hard to determine if loss of one or more proteins is responsible for the observed killing effects. On the physical side, PG is a single, gigantic covalently linked polymer that has been difficult to characterize at the level of resolution needed to understand the contribution of individual proteins. Among the things we need to know are what individual proteins do, when and where they do it, and how their activities affect the assembly of large protein complexes that pass through the PG layer to the outside of the cell. Such complexes include those involved in the key processes of motility, protein secretion and efflux of toxic compounds. Using bacteria lacking single PG-active enzymes, we have undertaken a long term research program to understand how the control of PG metabolism and structure intersects with assembly of cell-wall-spanning protein complexes. Through phenotypic screens, we have identified an amidase and a PBP that are required for normal assembly of motility and secretion systems; and a different PBP and a lytic transglycosylase that act as sentinels of cell wall damage as well as having roles in the assembly of drug efflux pumps, both processes that lead to antibiotic resistance. Our research will lead to new strategies to overcome antibiotic resistance, an increasingly serious problem threatening the health of Canadians, as strains resistant to all known antibiotics are already here.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
227817-2011
Name nom
Burrows, Lori
Department département
Biochemistry and Biomedical Sciences
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2011
Award amount
56000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5201
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Bacteriology
Research subject fr
Bactériologie
Partie
1
Nb partie
5
Application title
Role of peptidoglycan-active enzymes in the assembly of bacterial motility, secretion and efflux systems
Keyword
NSERC
Application summary
Peptidoglycan (PG) is a major structural component of bacterial cell walls but is absent in higher organisms. It is a strong, chain link fence-like material with a pore size of ~100 kDa. It completely surrounds bacteria, providing protection against high internal pressures and contributing to the formation of distinct bacterial cell shapes. Although PG is essential for bacterial viability and was identified decades ago as the target of the earliest antibiotics, the molecular details of its synthesis are only partly understood. In part, this lack of understanding has arisen because most bacteria have multiple, non-essential PG active enzymes with seemingly redundant activities, making it challenging to assign specific functions to individual proteins. Drugs such as penicillin that inhibit PG synthesis often target multiple enzymes simultaneously, making it hard to determine if loss of one or more proteins is responsible for the observed killing effects. On the physical side, PG is a single, gigantic covalently linked polymer that has been difficult to characterize at the level of resolution needed to understand the contribution of individual proteins. Among the things we need to know are what individual proteins do, when and where they do it, and how their activities affect the assembly of large protein complexes that pass through the PG layer to the outside of the cell. Such complexes include those involved in the key processes of motility, protein secretion and efflux of toxic compounds. Using bacteria lacking single PG-active enzymes, we have undertaken a long term research program to understand how the control of PG metabolism and structure intersects with assembly of cell-wall-spanning protein complexes. Through phenotypic screens, we have identified an amidase and a PBP that are required for normal assembly of motility and secretion systems; and a different PBP and a lytic transglycosylase that act as sentinels of cell wall damage as well as having roles in the assembly of drug efflux pumps, both processes that lead to antibiotic resistance. Our research will lead to new strategies to overcome antibiotic resistance, an increasingly serious problem threatening the health of Canadians, as strains resistant to all known antibiotics are already here.